← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 6, 2016Last known activity
Dec 13, 2018
Defunct as of Oct 1, 2019
Timeline
2010s
- Jun 1, 2012
Orygen Biotecnologia SA— Founded
- Oct 1, 2019
Orygen Biotecnologia SA— Defunct
Drugs by trial phase (2 distinct, 2 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT03799510CollaboratorPhase 2Dec 13, 2018
- NCT03041766CollaboratorPhase 2Dec 6, 2016
Details
- Founded
- Sao Paulo, BR Jun 1, 2012
- Last known activity
- Dec 13, 2018
Notes
No evidence still extant